Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Immunic Inc.

    NASDAQ: IMUX · Real-Time Price · USD
    0.80
    -0.04 (-5.20%)
    At close: Jun 13, 2025, 3:59 PM
    0.82
    2.37%
    After-hours: Jun 13, 2025, 07:26 PM EDT

    Immunic Statistics

    Share Statistics

    Immunic has 95.82M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 95.82M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 50.44%

    Shares Floating

    n/a
    		 92.59M

    Failed to Deliver (FTD) Shares

    n/a
    		 229

    FTD / Avg. Volume

    n/a
    		 0.02%

    Short Selling Information

    The latest short interest is 4.25M, so 4.43% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 4.25M

    Short % of Shares Out

    n/a
    		 4.43%

    Short % of Float

    n/a
    		 4.52%

    Short Ratio (days to cover)

    n/a
    		 2.28

    Valuation Ratios

    The PE ratio is -1 and the forward PE ratio is -1.48. Immunic's PEG ratio is 0.02.

    PE Ratio

    n/a
    		 -1

    Forward PE

    n/a
    		 -1.48

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 5.44

    P/FCF Ratio

    n/a
    		 -1.18

    PEG Ratio

    n/a
    		 0.02
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Immunic.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.77, with a Debt / Equity ratio of 0.05.

    Current Ratio

    n/a
    		 1.77

    Quick Ratio

    n/a
    		 1.77

    Debt / Equity

    n/a
    		 0.05

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,104,472.53

    Employee Count

    n/a
    		 91

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -32.77% in the last 52 weeks. The beta is 1.49, so Immunic's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.49

    52-Week Price Change

    n/a
    		 -32.77%

    50-Day Moving Average

    n/a
    		 0.95

    200-Day Moving Average

    n/a
    		 1.16

    Relative Strength Index (RSI)

    n/a
    		 42.81

    Average Volume (20 Days)

    n/a
    		 1,380,360

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -98.05M

    Net Income

    n/a
    		 -100.51M

    EBITDA

    n/a
    		 -100.37M

    EBIT

    n/a
    		 -100.51M

    Earnings Per Share (EPS)

    n/a
    		 -1
    Full Income Statement

    Balance Sheet

    The company has 35.67M in cash and 1M in debt, giving a net cash position of 34.66M.

    Cash & Cash Equivalents

    n/a
    		 35.67M

    Total Debt

    n/a
    		 1M

    Net Cash

    n/a
    		 34.66M

    Retained Earnings

    n/a
    		 -511.4M

    Total Assets

    n/a
    		 20.52M

    Working Capital

    n/a
    		 -6.62M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -84.77M and capital expenditures -264K, giving a free cash flow of -85.03M.

    Operating Cash Flow

    n/a
    		 -84.77M

    Capital Expenditures

    n/a
    		 -264K

    Free Cash Flow

    n/a
    		 -85.03M

    FCF Per Share

    n/a
    		 -0.85
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    IMUX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for IMUX is $10, which is 1150% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $10

    Price Target Difference

    n/a
    		 1150%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 7
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Apr 15, 2019. It was a backward split with a ratio of 1:40.

    Last Split Date

    n/a
    		 Apr 15, 2019

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:40

    Scores

    Altman Z-Score

    n/a
    		 179.35

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist